Park Medi World Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
PARKHOSPS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Park Medi World Limited reported strong audited results for FY2026 (year ended March 31, 2026). Consolidated revenue grew 20.5% to ₹16,794 million from ₹13,936 million in FY2025, while consolidated PAT rose 27.1% to ₹2,739 million from ₹2,154 million, with EPS of ₹6.87. Standalone PAT surged over 5x to ₹366 million on revenue of ₹1,290 million, boosted by the company's December 2025 IPO and multiple hospital acquisitions (KPS Wellness, SVPD Healthcare, Mahip Hospital) during the year. The company commenced a new 350-bed multi-specialty hospital in Panchkula in April 2026. Statutory auditors issued an unmodified opinion with no going concern issues. One subsidiary's results remain unaudited and were included based on management-prepared figures.
Strong earnings growth and expansion via acquisitions and new facility openings signal operational scale-up, though the large jump in standalone PAT reflects significant IPO-driven changes and should be viewed in the context of consolidated group performance.